acrolein has been researched along with Mycoses in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumari, A; Singh, K | 1 |
| Alves, AF; da Nóbrega Alves, D; da Silva Araújo, R; de Araújo, MRC; de Castro, RD; Melo, AKV | 1 |
| Singh, K | 1 |
1 trial(s) available for acrolein and Mycoses
| Article | Year |
|---|---|
Safety and tolerability of cinnamaldehyde in orabase for oral candidiasis treatment: phase I clinical trial.
Topics: Acrolein; Antifungal Agents; Candida; Candidiasis, Oral; Carboxymethylcellulose Sodium; Humans; Mycoses; Ointments | 2022 |
2 other study(ies) available for acrolein and Mycoses
| Article | Year |
|---|---|
Evaluation of prophylactic efficacy of cinnamaldehyde in murine model against Paradendryphiella arenariae mycotoxin tenuazonic acid-induced oxidative stress and organ toxicity.
Topics: Acrolein; Animals; Antioxidants; Ascomycota; Male; Mice; Mycoses; Plant Extracts; Tenuazonic Acid | 2021 |
Evaluation of antifungal activity of cinnamaldehyde against Cryptococcus neoformans var. grubii.
Topics: Acrolein; Animals; Antifungal Agents; Brain; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Resistance, Fungal; Liver; Lung; Mice; Microbial Sensitivity Tests; Mycoses; Survival Analysis | 2020 |